POLYTECH welcomes statement by US Food and Drug Administration FDA opposing ban on textured breast implants
POLYTECH Health & Aesthetics GmbH, a global leader in breast aesthetics, welcomes a recent statement by the FDA that tex…
POLYTECH Health & Aesthetics GmbH, a global leader in breast aesthetics, welcomes a recent statement by the FDA that tex…
Prima BioMed (ISIN US74154B2034) hat heute seinen Appendix 4C - Quartalsbericht für das 4. Quartal des Geschäftsjahres 2…